Research reference only. Not medical advice. Most compounds are not FDA-approved. These are research chemicals, not for human consumption. Consult a qualified clinician.Read methodology Terms update on 18 Dec 2026
← Back to Research Index
Compare Evaluate Matrix Half-Life
Dossier · № 78 of 110 Updated Nov 17, 2026

Cardiogen

Khavinson cardiac bioregulator

RUSSIAN RESEARCH · KHAVINSON SHORT PEPTIDE BIOREGULATOR

▓ 11 indexed citations across PubMed (10), ClinicalTrials.gov (1).

Citation breakdown by evidence tier

← weaker evidence  ·  stronger evidence →

11 citations across 2 tiers

Tap any tier to jump to that section of the bibliography.

Mechanism of action

Tissue-specific gene expression modulation in cardiomyocytes

Researched effects

Cardiac tissue support; cardioprotection in animal models

Live evidence

Recent literature

Live signals refreshed daily. Current as of November 19, 2026.

Dosing reported in literature

Oral capsule 1-2x daily

Known concerns

Limited Western evidence; no regulatory approval

Top-ranked picks

10 pre-curated authoritative sources, ranked by journal tier and study weight.

  1. Prospective Evaluation of Strontium in Patients After CardioGen-82 PET MPI Scanning

    2011 — TRIAL REGISTRATIONS (CLINICALTRIALS.GOV) · AUTHORITY 66.1

  2. Rubidium-82 generator yield and efficiency for PET perfusion imaging: Comparison of two clinical systems.

    Journal of nuclear cardiology : official publication of the American Society of Nuclear Cardiology · 2020 — RESEARCH ARTICLES · AUTHORITY 34.0

  3. Limitations of Rb-82 weight-adjusted dosing accuracy at low doses.

    Journal of nuclear cardiology : official publication of the American Society of Nuclear Cardiology · 2017 — RESEARCH ARTICLES · AUTHORITY 33.7

  4. [Cardiomyopathy and ion channel diseases registry: the Szeged CardioGen Registry].

    Orvosi hetilap · 2017 — RESEARCH ARTICLES · AUTHORITY 33.7

  5. An Analysis of 3 Common CardioGen-82 82Rb Infusion System Injection Methods and Their Impact on Clinical Volume and Image Counts.

    Journal of nuclear medicine technology · 2015 — RESEARCH ARTICLES · AUTHORITY 33.5

  6. Update on CardioGen-82.

    Journal of nuclear medicine : official publication, Society of Nuclear Medicine · 2012 — RESEARCH ARTICLES · AUTHORITY 33.2

  7. Recall of CardioGen-82.

    Journal of nuclear medicine : official publication, Society of Nuclear Medicine · 2011 — RESEARCH ARTICLES · AUTHORITY 33.1

  8. [Peptidergic regulation of the expression of signal factors of fibroblast differentiation in the human prostate gland in cell aging].

    Advances in gerontology = Uspekhi gerontologii · 2010 — RESEARCH ARTICLES · AUTHORITY 33.0

  9. Tumor-modifying effect of cardiogen peptide on M-1 sarcoma in senescent rats.

    Bulletin of experimental biology and medicine · 2009 — RESEARCH ARTICLES · AUTHORITY 32.9

  10. [The effect of the amino acids and cardiogen on the development of myocard tissue culture from young and old rats].

    Advances in gerontology = Uspekhi gerontologii · 2009 — RESEARCH ARTICLES · AUTHORITY 32.9

Full citation library

Year distribution

Trial Registrations (ClinicalTrials.gov)

1
  1. 1.

    NCT01424774 · Completed · 2011

    Conditions: Radiation Exposure

Research Articles

10
  1. 2.

    Ahmadi A, Klein R, Lewin HC, Beanlands RSB, et al. · Journal of nuclear cardiology : official publication of the American Society of Nuclear Cardiology · 2020 · PMID 32436115

    Strontium-82/Rubidium-82 ( N = 515 sequential daily quality assurance (QA) reports from 9 CardioGen-82 At the start of clinical use, the system reported

  2. 3.

    Moody JB, Hiller KM, Lee BC, Corbett JR, et al. · Journal of nuclear cardiology : official publication of the American Society of Nuclear Cardiology · 2017 · PMID 27184903

    Weight-adjusted dosing is important to maintain accurate quantification for dynamic cardiac three-dimensional positron emission tomography (PET). However, the manufacturer of the only Food and Drug Administration approved rubidium-82 (Rb-82) generator (CardioGen-82, Bracco Diagnostics, Inc.) recommends recalibration after each change in dose which is inefficient in a busy clinical PET lab. The objective of this study was to evaluate the accuracy of Rb-82 dosing without this recalibration. After…

  3. 4.

    Journal of nuclear medicine : official publication, Society of Nuclear Medicine · 2012 · PMID 22393230

  4. 5.

    Levdik NV, Knyazkin IV · Bulletin of experimental biology and medicine · 2009 · PMID 20396706

    The tumor-modifying effect of cardiogen peptide was studied on rats with transplanted M-1 sarcoma. The level of apoptosis of tumor cells after cardiogen injections in all experimental groups was higher than in the control. The dose-dependent inhibition of M-1 sarcoma growth after injection of cardiogen was caused by the development of hemorrhagic necrosis and stimulation of tumor cell apoptosis. The parameters of proliferative activity indicate that inhibition of tumor growth was not caused by t…

  5. 6.

    Blazsó P, Kákonyi K, Forster T, Sepp R · Orvosi hetilap · 2017 · PMID 28110572

    The Szeged cardiomyopathy and ion channel diseases registry aims to establish a representative disease-specific registry based on the recruitment of patients with different cardiomyopathies and ion channel diseases followed at the Cardiology Center, University of Szeged. The registry collects patient data on the main forms of primary cardiomyopathies (hypertrophic, dilated, restrictive, arrhythmogenic right ventricular, left ventricular non-compact, tako-tsubo cardiomyopathy) and ion channel dis…

  6. 7.

    Kheĭfets OV, Poliakova VO, Kvetnoĭ IM · Advances in gerontology = Uspekhi gerontologii · 2010 · PMID 20586252

    The effect of short peptides T-32, T-38 and cardiogen on the expression of signaling factors of the differentiation of human prostate's fibroblasts (PFM), which are the main cells of its microenvironment--protein CXCL12, WEDC1 and ghrelin in aging cultures has been studied. Confocal laser microscopy has demonstrated that all the investigated peptides possess the ability to actively enhance the expression of the above markers, whose synthesis significantly reduced in senescent cultures. It has be…

  7. 8.

    Journal of nuclear medicine : official publication, Society of Nuclear Medicine · 2011 · PMID 21885807

  8. 9.

    Zakutskiĭ AN, Chalisova NI, Ryzhak GA, Aniskina AI, et al. · Advances in gerontology = Uspekhi gerontologii · 2006 · PMID 17152728

    The synthetic peptides--cardiogen, bronchogen, prostamax and pancragen were used to investigate their effect on organotypic tissue culture of explants from heart, lungs, prostatic gland and pancreas of young (3-week old) and aged (18-month old) rats. The peptide effective concentration of 0.05 ng/ml showed a stimulating effect in appropriate tissue cultures as compared to the control explants in all groups of rats. So these bioregulatory peptides can be used in clinic practice for the stimulatio…

  9. 10.

    Chalisova NI, Lesniak VV, Balykina NA, Urt'eva SA, et al. · Advances in gerontology = Uspekhi gerontologii · 2009 · PMID 20210190

    The effect of 20 amino acids and the synthetic tetrapeptide cardiogen in concentration 10(-12) M was investigated in organotypic tissue culture on the cell proliferation and apoptosis development in myocard tissue explant in 3- and 24-months old rats. 7 of 20 amino acids stimulated the cell proliferation in the young rats. In the same time, only 2 amino acids were active in myocard culture from the old rats. The tetrapeptide cardiogen demonstrated the great stimulating effect on the proliferatio…

  10. 11.

    Roby AE, Johnson NP, Gould KL · Journal of nuclear medicine technology · 2015 · PMID 25956692

    In the wake of the Food and Drug Administration (FDA) recall, many clinics have had to reduce their examination volumes to meet the new generator volume usage requirements. This review tests 3 common infusion methods and how they affect patient dose, generator volume usage, image counts, and generator volume limits. Three common configurations of the (82)Rb infusion system settings--standard 50-mL, volume-limiting, and bolus methods--were tested to determine how they affect patient dose, generat…

Curated sources on file

3
  1. 1.
  2. 2.
  3. 3.
    Note: Primary literature on this peptide is published largely in Russian gerontology journals (Adv Gerontol, Bull Eksp Biol Med). English-indexed sources are limited to comprehensive Khavinson-laboratory reviews; entry confidence is correspondingly lower.

Continue reading